• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症心肌病小鼠模型的建立:探究慢性肾脏病对心脏功能及信号通路的影响

Development of a Mouse Model of Uremic Cardiomyopathy: Investigating the Impact of Chronic Kidney Disease on Cardiac Function and Signaling Pathway.

作者信息

Moellmann Julia, Glandien Katja, Klinkhammer Barbara M, Wollenhaupt Julia, Noels Heidi, Jankowski Joachim, Lebherz Corinna, Boor Peter, Lehrke Michael, Marx Nikolaus

机构信息

Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

Institute of Pathology, University Hospital Aachen, RWTH Aachen University, Aachen, Germany.

出版信息

FASEB J. 2025 May 31;39(10):e70639. doi: 10.1096/fj.202500281R.

DOI:10.1096/fj.202500281R
PMID:40386987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12086955/
Abstract

Patients with chronic kidney disease are at an increased risk of developing heart failure, but the underlying mechanisms remain incompletely understood, at least in part because of the paucity of mouse models of uremic cardiomyopathy. In this study, we used two different experimental setups of 2,8-dihydroxyadenine-induced nephropathy in different mouse strains to develop a non-invasive mouse model of uremic cardiomyopathy. Among the different models, only 129/Sv mice fed an adenine-supplemented diet for 16 weeks showed typical features of uremic cardiomyopathy. Kidney damage was confirmed by histopathologic findings of diffuse fibrosis with collagen deposition, crystal formation, and uremia. The cardiac phenotype showed significantly increased myocardial fibrosis associated with impaired cardiac contractility under dobutamine-induced stress conditions. This was associated with a significant activation of the mTOR pathway and downstream endoplasmic reticulum stress, increased apoptosis, and inflammation. Treatment of 129/Sv mice with an adenine-supplemented diet for 16 weeks represents a model of uremic cardiomyopathy with increased myocardial fibrosis and impaired cardiac function, as well as a shift from cardioprotective to detrimental signaling, increased endoplasmic reticulum stress, and inflammation.

摘要

慢性肾脏病患者发生心力衰竭的风险增加,但其潜在机制仍未完全明确,至少部分原因是尿毒症心肌病小鼠模型的匮乏。在本研究中,我们在不同小鼠品系中使用两种不同的2,8 - 二羟基腺嘌呤诱导肾病的实验设置,以建立一种非侵入性的尿毒症心肌病小鼠模型。在不同模型中,只有喂食含腺嘌呤饮食16周的129/Sv小鼠表现出尿毒症心肌病的典型特征。通过弥漫性纤维化伴胶原沉积、晶体形成和尿毒症的组织病理学发现证实了肾脏损伤。心脏表型显示,在多巴酚丁胺诱导的应激条件下,心肌纤维化显著增加,同时心脏收缩功能受损。这与mTOR通路和下游内质网应激的显著激活、细胞凋亡增加以及炎症有关。用含腺嘌呤饮食喂养16周的129/Sv小鼠代表了一种尿毒症心肌病模型,其心肌纤维化增加、心脏功能受损,同时信号传导从心脏保护转向有害,内质网应激增加以及炎症反应增强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d3/12086955/5da55dd6e174/FSB2-39-e70639-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d3/12086955/07a1ffc5ae5c/FSB2-39-e70639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d3/12086955/b9159e1f2e98/FSB2-39-e70639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d3/12086955/5da55dd6e174/FSB2-39-e70639-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d3/12086955/07a1ffc5ae5c/FSB2-39-e70639-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d3/12086955/b9159e1f2e98/FSB2-39-e70639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35d3/12086955/5da55dd6e174/FSB2-39-e70639-g004.jpg

相似文献

1
Development of a Mouse Model of Uremic Cardiomyopathy: Investigating the Impact of Chronic Kidney Disease on Cardiac Function and Signaling Pathway.尿毒症心肌病小鼠模型的建立:探究慢性肾脏病对心脏功能及信号通路的影响
FASEB J. 2025 May 31;39(10):e70639. doi: 10.1096/fj.202500281R.
2
The Worsening of Myocardial Ischemia-Reperfusion Injury in Uremic Cardiomyopathy is Further Aggravated by PM Exposure: Mitochondria Serve as the Central Focus of Pathology.尿毒症性心肌病中心肌缺血再灌注损伤恶化进一步加剧 PM 暴露的影响:线粒体作为病理学的核心焦点。
Cardiovasc Toxicol. 2024 Nov;24(11):1236-1252. doi: 10.1007/s12012-024-09920-y. Epub 2024 Sep 12.
3
Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease.慢性肾病多种鼠模型中促氧化预处理但维持心功能。
Redox Biol. 2022 Oct;56:102459. doi: 10.1016/j.redox.2022.102459. Epub 2022 Aug 30.
4
Differential Myocardial Responses in Male and Female Rats with Uremic Cardiomyopathy.尿毒症心肌病雄性和雌性大鼠的心肌差异反应
Int J Mol Sci. 2025 Mar 3;26(5):2259. doi: 10.3390/ijms26052259.
5
Early inflammatory changes and CC chemokine ligand-8 upregulation in the heart contribute to uremic cardiomyopathy.心脏早期炎症变化和CC趋化因子配体8上调促成尿毒症心肌病。
FASEB J. 2021 Aug;35(8):e21761. doi: 10.1096/fj.202100746R.
6
2,8-Dihydroxyadenine-induced nephropathy causes hexosylceramide accumulation with increased mTOR signaling, reduced levels of protective SirT3 expression and impaired renal mitochondrial function.2,8-二羟腺嘌呤诱导的肾病导致己糖神经酰胺积累,增加了 mTOR 信号,降低了保护性 SirT3 表达水平,并损害了肾脏线粒体功能。
Biochim Biophys Acta Mol Basis Dis. 2024 Jan;1870(1):166825. doi: 10.1016/j.bbadis.2023.166825. Epub 2023 Aug 1.
7
Uremic cardiomyopathy and insulin resistance: a critical role for akt?尿毒症性心肌病和胰岛素抵抗:akt 的关键作用?
J Am Soc Nephrol. 2011 Feb;22(2):207-15. doi: 10.1681/ASN.2009090900. Epub 2010 Jul 15.
8
Roles of AhR/CYP1s signaling pathway mediated ROS production in uremic cardiomyopathy.AhR/CYP1s 信号通路介导的 ROS 产生在尿毒症性心肌病中的作用。
Toxicol Lett. 2024 May 15;396:81-93. doi: 10.1016/j.toxlet.2024.04.005. Epub 2024 Apr 24.
9
Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.比较氯沙坦和米拉贝隆在尿毒症性心肌病大鼠模型中的抗重构作用。
Sci Rep. 2021 Sep 1;11(1):17495. doi: 10.1038/s41598-021-96815-5.
10
Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic Signaling.雷帕霉素通过降低海蟾蜍毒素水平和抑制下游促纤维化信号减轻实验性尿毒症心肌病中的心脏纤维化。
J Am Heart Assoc. 2016 Sep 30;5(10):e004106. doi: 10.1161/JAHA.116.004106.

本文引用的文献

1
Post-translational modifications in kidney diseases and associated cardiovascular risk.肾脏疾病中的翻译后修饰及其相关心血管风险。
Nat Rev Nephrol. 2024 Aug;20(8):495-512. doi: 10.1038/s41581-024-00837-x. Epub 2024 Apr 25.
2
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.新型全雌激素受体激动剂通过增强心脏脂肪酸代谢和线粒体功能改善心力衰竭。
Circulation. 2024 Jan 16;149(3):227-250. doi: 10.1161/CIRCULATIONAHA.123.066542. Epub 2023 Nov 14.
3
Cardiomyopathy in chronic kidney disease: clinical features, biomarkers and the contribution of murine models in understanding pathophysiology.
慢性肾脏病中的心肌病:临床特征、生物标志物及小鼠模型在理解病理生理学中的作用
Clin Kidney J. 2023 Apr 18;16(11):1786-1803. doi: 10.1093/ckj/sfad085. eCollection 2023 Nov.
4
Neuregulin-1β Improves Uremic Cardiomyopathy and Renal Dysfunction in Rats.神经调节蛋白-1β改善大鼠尿毒症性心肌病和肾功能障碍。
JACC Basic Transl Sci. 2023 May 31;8(9):1160-1176. doi: 10.1016/j.jacbts.2023.03.003. eCollection 2023 Sep.
5
2,8-Dihydroxyadenine-induced nephropathy causes hexosylceramide accumulation with increased mTOR signaling, reduced levels of protective SirT3 expression and impaired renal mitochondrial function.2,8-二羟腺嘌呤诱导的肾病导致己糖神经酰胺积累,增加了 mTOR 信号,降低了保护性 SirT3 表达水平,并损害了肾脏线粒体功能。
Biochim Biophys Acta Mol Basis Dis. 2024 Jan;1870(1):166825. doi: 10.1016/j.bbadis.2023.166825. Epub 2023 Aug 1.
6
The Cardio-Kidney Patient: Epidemiology, Clinical Characteristics and Therapy.心肾患者:流行病学、临床特征和治疗。
Circ Res. 2023 Apr 14;132(8):902-914. doi: 10.1161/CIRCRESAHA.122.321748. Epub 2023 Apr 13.
7
Additive interaction of diabetes mellitus and chronic kidney disease in cancer patient mortality risk.糖尿病和慢性肾脏病在癌症患者死亡风险中的相加交互作用。
Sci Rep. 2022 Nov 19;12(1):19957. doi: 10.1038/s41598-022-24466-1.
8
Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease.慢性肾病多种鼠模型中促氧化预处理但维持心功能。
Redox Biol. 2022 Oct;56:102459. doi: 10.1016/j.redox.2022.102459. Epub 2022 Aug 30.
9
The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis.钠-葡萄糖协同转运蛋白 2 抑制剂依帕列净改变了心脏底物代谢的特征,并减少了心脏 mTOR 信号、内质网应激和细胞凋亡。
Diabetes Obes Metab. 2022 Nov;24(11):2263-2272. doi: 10.1111/dom.14814. Epub 2022 Aug 1.
10
A systematic review and meta-analysis of murine models of uremic cardiomyopathy.一项关于尿毒症性心肌病的小鼠模型的系统评价和荟萃分析。
Kidney Int. 2022 Feb;101(2):256-273. doi: 10.1016/j.kint.2021.10.025. Epub 2021 Nov 11.